Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 281.45 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:06 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

suven life sciences ltd (SVLS) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/15/15 - 338.50
52 Week Low
10/13/14 - 176.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SUVEN LIFE SCIENCES LTD (SVLS)

Related News

No related news articles were found.

suven life sciences ltd (SVLS) Related Businessweek News

No Related Businessweek News Found

suven life sciences ltd (SVLS) Details

Suven Life Sciences Limited, a biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and fine chemicals for the life science industry worldwide. It provides advanced intermediates, intermediates, active pharmaceutical ingredients, and stock chemicals. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities. In addition, it provides discovery and development of new chemical entities for CNS disorders; research collaborative projects with pharmaceutical companies; and drug discovery research services, such as in-vitro screening and molecular biology, drug metabolism and pharmacokinetics, pharmacology, toxicology, and bioanalysis, as well as operates a formulation development center. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. Suven Life Sciences Limited was founded in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

881 Employees
Last Reported Date: 05/26/15
Founded in 1989

suven life sciences ltd (SVLS) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: 14.5M
Whole-Time Director, Member of Share Transfer...
Total Annual Compensation: 6.9M
Compensation as of Fiscal Year 2015.

suven life sciences ltd (SVLS) Key Developments

Suven Life Sciences Commences Phase 1 Clinical Trial in USA under USIND 126099

Suven Life Sciences announced their NCE SUVN-D4010 has commenced Phase 1 clinical trial in USA. SUVN-D4010 is a potent, selective, brain penetrant and orally active 5-HT4 receptor partial agonist for the treatment of cognitive dysfunction associated with Alzheimer's disease and other dementias. Suven submitted Investigational New Drug Application (IND) to US FDA to conduct Phase-1 clinical trial for Cognition in Alzheimer's Disease, under 505(1) of the Federal Food, Drug and Cosmetic Act (FDCA) which was assigned an IND number 126099. Based on the IND no: 126099, 'A Single Center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the safety, Tolerability, and Pharmacokinetics of SUVN-D4010 after Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects' for Cognition in Alzheimer's Disease is underway in USA.

Suven Life Sciences Ltd Board Approves to Create an Overseas Subsidiary

Suven Life Sciences Ltd. has informed that the Board of Directors of the Company at its meeting held on August 14, 2015, has authorized to create an overseas subsidiary with an initial investment of USD 25 million for clinical development and commercialization of Suven pipeline and in-licensed molecules.

Suven Life Sciences Limited Approves Dividend on Equity Shares for the Fiscal Year 2015

Suven Life Sciences Limited has approved the dividend of INR 0.60 per equity share of INR 1 each for the fiscal year 2015 at the AGM held on Aug. 14, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVLS:IN 281.45 INR -0.40

SVLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SVLS.
View Industry Companies

Industry Analysis


Industry Average

Valuation SVLS Industry Range
Price/Earnings 36.1x
Price/Sales 7.3x
Price/Book 6.3x
Price/Cash Flow 33.2x
TEV/Sales 6.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUVEN LIFE SCIENCES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at